Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Mary Maluccio, MD, MPH, FACS
Translational Oncology
LSU Health - New Orleans
Tarun Mandal PhD
Translational Oncology
Xavier University
Elizabeth Martin, PhD
Cancer Biology
Tulane University School of Medicine
Marc Matrana MD
Translational Oncology
Ochsner Health
Michelle Matter PhD
Cancer Biology
Tulane University School of Medicine
Georgios Matthaiolampakis PhD
Translational Oncology
University of Louisiana Monroe
Yevette Bren Mattison, PhD
Translational Oncology
LSU Health - New Orleans
Harris McFerrin, PhD
Genes X Environment
Xavier University
Kacie Mennie, PhD
Population Sciences
Louisiana Tech University